Molecular heterogeneity in breast carcinoma cells with increased invasive capacities
Authors
Giulia Negro
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium
Bertram Aschenbrenner
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium
Simona Kranjc Brezar
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Maja Cemazar
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
University of Primorska, Faculty of Health Sciences, Izola, Slovenia
EORTC PathoBiology Group, Brussels, Belgium
Andrej Coer
University of Primorska, Faculty of Health Sciences, Izola, Slovenia
Orthopaedic Hospital Valdoltra, Ankaran, Slovenia
Gorana Gasljevic
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Dragana Savic
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium
Maxim Sorokin
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Omicsway Corp, Walnut, USA
EORTC PathoBiology Group, Brussels, Belgium
Anton Buzdin
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Oncobox ltd, Moscow, Russia
EORTC PathoBiology Group, Brussels, Belgium
Maurizio Callari
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
EORTC PathoBiology Group, Brussels, Belgium
Irma Kvitsaridze
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium
Anahid Jewett
Division of Oral Biology and Medicine Microbiology, Immunology, & Molecular Genetics, Tumor Immunology Laboratory, College of Letters & Science, UCLA School of Dentistry and Medicine, Los Angeles, USA
Mariela Vasileva-Slaveva
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium
Ute Ganswindt
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Ira Skvortsova
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium
Sergej Skvortsov
Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
Language: English
Page range: 103 - 118
Submitted on: Jan 10, 2020
Accepted on: Jan 30, 2020
Published on: Feb 14, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Giulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, Maja Cemazar, Andrej Coer, Gorana Gasljevic, Dragana Savic, Maxim Sorokin, Anton Buzdin, Maurizio Callari, Irma Kvitsaridze, Anahid Jewett, Mariela Vasileva-Slaveva, Ute Ganswindt, Ira Skvortsova, Sergej Skvortsov, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.